JP5013516B2 - Medical rubber member, sterilized medical rubber member, and rubber composition - Google Patents

Medical rubber member, sterilized medical rubber member, and rubber composition Download PDF

Info

Publication number
JP5013516B2
JP5013516B2 JP2007175724A JP2007175724A JP5013516B2 JP 5013516 B2 JP5013516 B2 JP 5013516B2 JP 2007175724 A JP2007175724 A JP 2007175724A JP 2007175724 A JP2007175724 A JP 2007175724A JP 5013516 B2 JP5013516 B2 JP 5013516B2
Authority
JP
Japan
Prior art keywords
medical rubber
medical
rubber
sterilized
cap
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2007175724A
Other languages
Japanese (ja)
Other versions
JP2009011518A (en
Inventor
弘毅 西尾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shin Etsu Polymer Co Ltd
Original Assignee
Shin Etsu Polymer Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shin Etsu Polymer Co Ltd filed Critical Shin Etsu Polymer Co Ltd
Priority to JP2007175724A priority Critical patent/JP5013516B2/en
Publication of JP2009011518A publication Critical patent/JP2009011518A/en
Application granted granted Critical
Publication of JP5013516B2 publication Critical patent/JP5013516B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Description

本発明は、医療用ゴム部材、滅菌済医療用ゴム部材及びゴム組成物に関し、さらに詳しくは、γ線等の照射による放射線滅菌を行っても劣化しにくい医療用ゴム部材、γ線等の照射による放射線滅菌処理してなる滅菌済医療用ゴム部材及び医療用ゴム部材を製造するのに使用されるゴム組成物に関する。   The present invention relates to a medical rubber member, a sterilized medical rubber member, and a rubber composition. More specifically, the present invention relates to a medical rubber member that is not easily deteriorated by radiation sterilization by irradiation of γ rays or the like, irradiation of γ rays or the like. The present invention relates to a sterilized medical rubber member and a rubber composition used for producing a medical rubber member obtained by radiation sterilization treatment according to the above.

従来、医療機器等に、金属材料に代わってゴム材料又は樹脂材料等で形成された医療用ゴム部材又は医療用樹脂部材(以下、これらを医療用部材と称する。)が用いられている。このような医療用ゴム部材として、例えば、薬液瓶の薬液注入口を閉塞する医療用ゴムボタン又は医療用ゴムキャップ、人工心臓等の血液回路又は人工透析等の体液回路等における混注管に設けられる医療用ゴムボタン又は医療用ゴムキャップ等が挙げられ、また、これらの医療用ゴムボタン又は医療用ゴムキャップ等であって、注射針等が刺される針刺栓等が挙げられる。一方、医療用樹脂部材として、例えば、カテーテル、チューブ、輸血バッグ及び血液バッグ等が挙げられる。   Conventionally, a medical rubber member or a medical resin member (hereinafter referred to as a medical member) formed of a rubber material or a resin material or the like instead of a metal material is used in a medical device or the like. As such a medical rubber member, for example, a medical rubber button or a medical rubber cap for closing a chemical injection port of a chemical liquid bottle, a blood injection circuit such as an artificial heart, a body fluid circuit such as artificial dialysis, or the like is provided in a mixed injection tube. Examples thereof include medical rubber buttons or medical rubber caps, and these medical rubber buttons or medical rubber caps include needle insertion plugs that are inserted with injection needles and the like. On the other hand, examples of the medical resin member include a catheter, a tube, a blood transfusion bag, a blood bag, and the like.

これらの医療用部材は、通常、製造の最終段階で、又は、使用前に、滅菌処理される。滅菌処理は、例えば、医療用部材を高温高圧で滅菌する高圧蒸気滅菌処理、医療用部材をエチレンオキサイドで処理するエチレンオキサイド滅菌処理、及び、医療用部材に放射線を照射する放射線滅菌処理等が挙げられる。これらの滅菌処理の中でも、適用範囲が広く、滅菌処理後の安全性を確保することができるうえ、医療用部材を十分に滅菌することができる放射線滅菌処理が、近年、採用されるようになってきている。   These medical members are usually sterilized at the final stage of manufacture or prior to use. Examples of the sterilization treatment include high-pressure steam sterilization treatment for sterilizing medical members at high temperature and high pressure, ethylene oxide sterilization treatment for treating medical members with ethylene oxide, and radiation sterilization treatment for irradiating medical members with radiation. It is done. Among these sterilization treatments, radiation sterilization treatments that have a wide range of application, can ensure safety after sterilization treatments, and can sufficiently sterilize medical members have recently been adopted. It is coming.

ところが、放射線滅菌処理によって医療用部材を滅菌すると、特に、医療用部材を高い照射量で十分に滅菌すると、医療用部材を構成するゴム材料又は樹脂材料のその物性等が変化し、医療用部材が劣化することがある。放射線照射に伴う劣化を抑えることを目的とする医療用部材として、例えば、「生体内で利用される高分子に、高分子との比を0.01〜20重量部の範囲で多官能トリアジン化合物を含有させた組成物から成る放射線滅菌可能な医用材料」が特許文献1に記載されている。   However, when a medical member is sterilized by radiation sterilization treatment, particularly when the medical member is sufficiently sterilized with a high dose, the physical properties of the rubber material or resin material constituting the medical member changes, and the medical member May deteriorate. As a medical member for the purpose of suppressing deterioration due to radiation irradiation, for example, “a polyfunctional triazine compound in a ratio of 0.01 to 20 parts by weight of a polymer to be used in a living body in a range of 0.01 to 20 parts by weight” Patent Document 1 describes a medical material that can be sterilized by radiation, which comprises a composition containing the same.

特開2003−965号公報JP 2003-965 A

この発明は、γ線等の照射による放射線滅菌を行っても劣化しにくい医療用ゴム部材、γ線等の照射による放射線滅菌処理してなる滅菌済医療用ゴム部材、及び、γ線等の照射による放射線滅菌を行っても劣化しにくい医療用ゴム部材を製造するのに用いられるゴム組成物を提供することを、目的とする。   The present invention relates to a medical rubber member that is not easily deteriorated by radiation sterilization by irradiation with gamma rays, a sterilized medical rubber member that has been subjected to radiation sterilization by irradiation with gamma rays, and irradiation with gamma rays. An object of the present invention is to provide a rubber composition used for producing a medical rubber member which is not easily deteriorated even if radiation sterilization is performed.

前記課題を解決するための手段として、
請求項1は、100質量部のシリコーンゴムと20質量部以上45質量部以下の無水ケイ酸とを含有し、銀イオン含有無機系抗菌剤無含有のゴム組成物を成形して成る医療用ゴム部材に放射線滅菌処理を施してなる滅菌済医療用ゴムキャップ又は医療用ゴムボタンであって、50kGyの照射量でγ線を照射する放射線滅菌処理前後における引裂き強度の変化率が−25%以上0%以下であることを特徴とする滅菌済医療用ゴムキャップ又は医療用ゴムボタンであり、
請求項2は、前記無水ケイ酸は少なくとも95質量%の二酸化ケイ素及び多くとも5質量%の水を含有していることを特徴とする請求項1に記載の滅菌済医療用ゴムキャップ又は医療用ゴムボタンであり、
請求項3は、前記無水ケイ酸は一次粒子径が0.001μm以上10μm以下であることを特徴とする請求項1又は2に記載の滅菌済医療用ゴムキャップ又は医療用ゴムボタンであり、
請求項4は、前記無水ケイ酸は40g/L以上70g/L以下の見掛け比重を有していることを特徴とする請求項1〜3のいずれか1項に記載の滅菌済医療用ゴムキャップ又は医療用ゴムボタンであり、
請求項5は、前記ゴム組成物は親水性付与剤としてポリエーテル変性シリコーンオイル又はカルビノール変性シリコーンオイルを含有していないことを特徴とする請求項1〜4のいずれか1項に記載の滅菌済医療用ゴムキャップ又は医療用ゴムボタンである
As means for solving the problems,
A medical rubber comprising a rubber composition containing 100 parts by mass of silicone rubber and 20 parts by mass or more and 45 parts by mass or less of anhydrous silicic acid, and containing no silver ion-containing inorganic antibacterial agent. A sterilized medical rubber cap or medical rubber button formed by subjecting a member to radiation sterilization treatment, and the rate of change in tear strength before and after radiation sterilization treatment in which γ-rays are irradiated at a dose of 50 kGy is -25% or more 0 % , A sterilized medical rubber cap or a medical rubber button ,
The sterilized medical rubber cap or medical use according to claim 1, characterized in that the silicic anhydride contains at least 95% by weight silicon dioxide and at most 5% by weight water. Rubber button ,
Claim 3 is the sterilized medical rubber cap or medical rubber button according to claim 1 or 2 , wherein the silicic acid anhydride has a primary particle size of 0.001 µm to 10 µm .
The sterilized medical rubber cap according to any one of claims 1 to 3 , wherein the silicic acid anhydride has an apparent specific gravity of 40 g / L or more and 70 g / L or less. Or a medical rubber button ,
The sterilization according to any one of claims 1 to 4 , wherein the rubber composition does not contain a polyether-modified silicone oil or a carbinol-modified silicone oil as a hydrophilicity imparting agent. It is a finished medical rubber cap or a medical rubber button .

この発明に係る医療用ゴム部材は、100質量部のシリコーンゴムと20質量部以上45質量部以下の無水ケイ酸とを含有するゴム組成物を成形して成るから、放射線滅菌処理において、γ線等の放射線を照射しても、その物性等が大きく変化することはない。したがって、この発明によれば、γ線等の照射による放射線滅菌を行っても劣化しにくい医療用ゴム部材を提供することができ、また、γ線等の照射による放射線滅菌処理してなる滅菌済医療用ゴム部材を提供することができる。   The medical rubber member according to the present invention is formed by molding a rubber composition containing 100 parts by mass of silicone rubber and 20 parts by mass or more and 45 parts by mass or less of silicic acid anhydride. The physical properties and the like do not change greatly even when irradiated with radiation such as. Therefore, according to the present invention, it is possible to provide a medical rubber member that is not easily deteriorated even by radiation sterilization by irradiation with γ rays or the like, and is sterilized that has been subjected to radiation sterilization treatment by irradiation with γ rays or the like. A medical rubber member can be provided.

また、この発明に係るゴム組成物は、医療用ゴム部材としたときに、放射線滅菌処理において、γ線等の放射線が照射されても、その物性等が大きく変化することはないから、γ線等の照射による放射線滅菌を行っても劣化しにくい医療用ゴム部材を製造するのに使用される。したがって、この発明によれば、γ線等の照射による放射線滅菌を行っても劣化しにくい医療用ゴム部材を製造するのに用いられるゴム組成物を提供することができる。   In addition, when the rubber composition according to the present invention is used as a medical rubber member, the physical properties and the like of the rubber composition are not greatly changed even when irradiated with radiation such as γ rays in the radiation sterilization treatment. It is used to manufacture a medical rubber member that is not easily deteriorated even by radiation sterilization by irradiation. Therefore, according to the present invention, it is possible to provide a rubber composition used for producing a medical rubber member which is not easily deteriorated even by radiation sterilization by irradiation with γ rays or the like.

まず、この発明に係るゴム組成物について説明する。このゴム組成物は、100質量部のシリコーンゴムと20質量部以上45質量部以下の無水ケイ酸とを含有する。前記質量割合の無水ケイ酸とシリコーンゴムとを含有すると、医療用ゴム部材としたときに、放射線滅菌処理において、γ線等の放射線が照射されても、医療用ゴム部材の物性等が大きく変化することを防止することができる。その理由の1つとして、例えば、無水ケイ酸が医療用ゴム部材の表面全体を覆っていなくても、医療用ゴム部材に含有される無水ケイ酸によって、放射線照射による医療用ゴム部材内部への酸素分子の侵入及び/又は拡散を効果的に防ぐことができ、それ故、シリコーンゴムの分解を抑えて、医療用ゴム部材の耐放射線性が向上することが考えられる。したがって、この発明に係るゴム組成物は、医療用ゴム部材を製造するのに好適に使用される。   First, the rubber composition according to the present invention will be described. This rubber composition contains 100 parts by mass of silicone rubber and 20 parts by mass or more and 45 parts by mass or less of silicic acid anhydride. When the above-mentioned mass proportion of silicic acid anhydride and silicone rubber is contained, when used as a medical rubber member, the physical properties of the medical rubber member greatly change even when irradiated with radiation such as γ-rays in the radiation sterilization process. Can be prevented. As one of the reasons, for example, even if silicic acid anhydride does not cover the entire surface of the medical rubber member, the silicic acid contained in the medical rubber member causes the radiation to the inside of the medical rubber member. It is conceivable that the invasion and / or diffusion of oxygen molecules can be effectively prevented, so that the decomposition of the silicone rubber is suppressed and the radiation resistance of the medical rubber member is improved. Therefore, the rubber composition according to the present invention is suitably used for producing a medical rubber member.

ゴム組成物に含有される前記シリコーンゴムは、平均組成式:RSi0(4−n)/2(Rは、置換又は非置換の一価炭化水素基、好ましくは炭素原子数1〜12の一価脂肪族炭化水素基、より好ましくは炭素原子数1〜6の一価脂肪族炭化水素基であり、nは1.8〜2.5、好ましくは2.0〜2.2である。)で示されるオルガノポリシロキサンを好適に挙げることができる。 The silicone rubber contained in the rubber composition has an average composition formula: R n Sio (4-n) / 2 (R is a substituted or unsubstituted monovalent hydrocarbon group, preferably having 1 to 12 carbon atoms. A monovalent aliphatic hydrocarbon group, more preferably a monovalent aliphatic hydrocarbon group having 1 to 6 carbon atoms, and n is 1.8 to 2.5, preferably 2.0 to 2.2. An organopolysiloxane represented by () can be preferably mentioned.

前記Rとしては、例えば、メチル基、エチル基、プロピル基、ブチル基、ヘキシル基及びドデシル基等のアルキル基、シクロヘキシル基等のシクロアルキル基、ビニル基、アリル基、ブテニル基及びヘキセニル基等のアルケニル基、フェニル基及びトリル基等のアリール基、β−フェニルプロピル基等のアラルキル基、並びに、これらの基の炭素原子に結合した水素原子の一部又は全部をハロゲン原子又はシアノ基等で置換したクロロメチル基、トリフルオロプロピル基及びシアノエチル基等が挙げられる。   Examples of R include alkyl groups such as methyl, ethyl, propyl, butyl, hexyl and dodecyl, cycloalkyl such as cyclohexyl, vinyl, allyl, butenyl and hexenyl. Alkyl groups such as alkenyl groups, phenyl groups and tolyl groups, aralkyl groups such as β-phenylpropyl groups, and some or all of the hydrogen atoms bonded to carbon atoms of these groups are substituted with halogen atoms or cyano groups. Chloromethyl group, trifluoropropyl group, cyanoethyl group and the like.

このオルガノポリシロキサンは、分子中に少なくとも2個の前記アルケニル基を有するのが好ましく、すなわち、前記Rは、アルキル基及びアルケニル基であるのが好ましく、メチル基及びビニル基等が特に好ましい。アルキル基とアルケニル基との割合は、アルキル基が98〜99.999モル%で、アルケニル基が0.001〜2モル%であるのが好ましい。   The organopolysiloxane preferably has at least two alkenyl groups in the molecule, that is, the R is preferably an alkyl group and an alkenyl group, and particularly preferably a methyl group and a vinyl group. The ratio of the alkyl group to the alkenyl group is preferably 98 to 99.999 mol% for the alkyl group and 0.001 to 2 mol% for the alkenyl group.

アルキル基及びアルケニル基を含有するオルガノポリシロキサンは、例えば、アルキルビニルポリシロキサン及び/又はジアルキルポリシロキサン等が挙げられる。ゴム組成物がこのようなシリコーンゴムを含有していると、医療用ゴム部材としたときに、医療用ゴム部材の耐薬品性、安全性及びゴム弾性等に優れる。シリコーンゴムは、これらの中でも、アルケニル基を有しないシリコーンゴムとしてジメチルポリシロキサン等が好ましく、アルケニル基を有するシリコーンゴムとしてメチルビニルポリシロキサン等が好ましい。   Examples of the organopolysiloxane containing an alkyl group and an alkenyl group include alkyl vinyl polysiloxane and / or dialkyl polysiloxane. When the rubber composition contains such a silicone rubber, the medical rubber member is excellent in chemical resistance, safety, rubber elasticity and the like when used as a medical rubber member. Among these, dimethylpolysiloxane and the like are preferable as the silicone rubber having no alkenyl group, and methylvinylpolysiloxane and the like are preferable as the silicone rubber having an alkenyl group.

オルガノポリシロキサンは、その重合度が500以上20,000以下であるのが好ましく、5,000以上15,000以下であるのが特に好ましい。オルガノポリシロキサンが前記範囲の重合度を有すると、医療用ゴム部材の機械的強度が向上する。オルガノポリシロキサンの重合度は、ゲル浸透クロマトグラフィー(GPC:Gel Permeation Chromatography)によって、標準ポリスチレン換算分子量として、測定されることができる。   The degree of polymerization of the organopolysiloxane is preferably 500 or more and 20,000 or less, and particularly preferably 5,000 or more and 15,000 or less. When the organopolysiloxane has a degree of polymerization in the above range, the mechanical strength of the medical rubber member is improved. The degree of polymerization of the organopolysiloxane can be measured by gel permeation chromatography (GPC: Gel Permeation Chromatography) as a standard polystyrene equivalent molecular weight.

シリコーンゴムは、適宜製造してもよく、市販品を使用してもよい。市販品としては、例えば、商品名「KE−530U」(信越化学工業株式会社製、重合度約8,000)、商品名「SH1123U」(ダウコーニング株式会社製、重合度約8,000)、及び、商品名「TSE211−3U」(GE東芝シリコーン株式会社製、重合度約8,000)等が挙げられる。   Silicone rubber may be produced as appropriate, or a commercially available product may be used. As a commercial item, for example, trade name “KE-530U” (manufactured by Shin-Etsu Chemical Co., Ltd., degree of polymerization of about 8,000), trade name “SH1123U” (manufactured by Dow Corning Co., Ltd., degree of polymerization of about 8,000), And trade name “TSE 211-3U” (manufactured by GE Toshiba Silicone Co., Ltd., degree of polymerization of about 8,000).

シリコーンゴムは、一種がゴム組成物に含有されてもよく、また、二種以上がゴム組成物に含有されてもよい。   One kind of silicone rubber may be contained in the rubber composition, or two or more kinds may be contained in the rubber composition.

この発明に係るゴム組成物に含有される前記無水ケイ酸は、乾式シリカ又は乾式法シリカとも称されることがあり、SiOの正四面体構造のすべての酸素をそれぞれ異なったケイ素が共有する三次元的に連なった分子構造を持っている(例えば、「化学辞典」(株式会社東京化学同人)参照。)。この無水ケイ酸は、通常、その含水量が多くとも5質量%であり、二酸化ケイ素の含有量が少なくとも95質量%である。無水ケイ酸は、その含水量が多くとも3質量%であるのが、放射線照射による物性等の変化を効果的に防止することができる点で、好ましい。なお、無水ケイ酸の含水量は、無水ケイ酸を、150℃に1時間加熱し、加熱前の質量と加熱後の質量との減少量を加熱後の質量で除した値を百分率で表した値である。 The silicic acid anhydride contained in the rubber composition according to the present invention may be referred to as dry silica or dry process silica, and different silicons share all oxygen in the tetrahedral structure of SiO 4. It has a three-dimensionally linked molecular structure (see, for example, “Chemical Dictionary” (Tokyo Kagaku Dojin)). The silicic anhydride usually has a water content of at most 5% by weight and a silicon dioxide content of at least 95% by weight. Silica anhydride preferably has a water content of at most 3% by mass because it can effectively prevent changes in physical properties and the like due to radiation irradiation. The water content of silicic acid was expressed as a percentage obtained by heating silicic acid to 150 ° C. for 1 hour and dividing the decrease in mass before heating and mass after heating by the mass after heating. Value.

無水ケイ酸は、湿式シリカと称される含水ケイ酸よりも見掛比重が小さく、通常、40〜70g/Lの見掛け比重を有する。無水ケイ酸が前記範囲の見掛比重を有すると、医療用ゴム部材の機械的強度が向上する。無水ケイ酸の見掛け比重は、ISO787/11に規定された測定方法に基づいて、メスシリンダに無水ケイ酸を入れて、タッピングした後に、その質量と体積から算出して求めた値である。   Anhydrous silicic acid has a smaller apparent specific gravity than hydrous silicic acid called wet silica, and usually has an apparent specific gravity of 40 to 70 g / L. When the anhydrous silicic acid has an apparent specific gravity in the above range, the mechanical strength of the medical rubber member is improved. The apparent specific gravity of silicic acid anhydride is a value obtained by calculating from its mass and volume after putting silicic acid anhydride into a graduated cylinder and tapping on the basis of the measurement method defined in ISO787 / 11.

無水ケイ酸は、BET比表面積が、100m/g以上400m/g以下であるのが好ましく、250m/g以上350m/g以下であるのが特に好ましい。無水ケイ酸が前記範囲のBET比表面積を有すると、放射線滅菌処理に対して、白濁等の外観上の変化が起こらず、また、引裂き強度、硬度等の機械的物性が大きく低下することを防止することができる。BET比表面積は、窒素ガス吸着量によって測定するBET1点法により測定された値である。 Silicic anhydride preferably has a BET specific surface area of 100 m 2 / g or more and 400 m 2 / g or less, and particularly preferably 250 m 2 / g or more and 350 m 2 / g or less. When the silicic acid anhydride has a BET specific surface area within the above range, no change in appearance such as white turbidity will occur with respect to radiation sterilization treatment, and mechanical properties such as tearing strength and hardness will not be significantly reduced. can do. The BET specific surface area is a value measured by the BET one-point method which is measured by the nitrogen gas adsorption amount.

無水ケイ酸は、その一次粒子径が、0.001μm以上10μm以下であるのが好ましく、0.01μm以上1μm以下であるのが特に好ましい。無水ケイ酸が前記範囲の一次粒子径を有すると、後述するシリコーンゴムに対して均一に分散することができ、医療用ゴム部材としたときの機械的物性が向上する。一次粒子径は、膨潤圧縮法で測定したときの値である。   The primary particle size of silicic anhydride is preferably 0.001 μm or more and 10 μm or less, and particularly preferably 0.01 μm or more and 1 μm or less. When the anhydrous silicic acid has a primary particle diameter in the above range, it can be uniformly dispersed in the silicone rubber described later, and the mechanical properties when used as a medical rubber member are improved. The primary particle diameter is a value measured by a swelling compression method.

無水ケイ酸は、通常、乾式法によって製造される。乾式法は、1000℃以上の高温下で、微粉無水ケイ酸粒子を生成させる方法で、燃焼法と加熱法とがある。燃焼法は、気化させた四塩化ケイ素と水素を混合し、1000℃以上1200℃以下の温度範囲で、空気中で燃焼させる方法であり、微細な粒子状の無水ケイ酸を製造することができる。加熱法は、ケイ砂とコークスをアーク炉中で加熱、還元させて発生するSiO蒸気を空気中の酸素で酸化させる方法であり、微細な粒子状の無水ケイ酸を製造することができる。   Silicic anhydride is usually produced by a dry method. The dry method is a method of generating finely powdered silicic acid particles at a high temperature of 1000 ° C. or higher, and includes a combustion method and a heating method. The combustion method is a method in which vaporized silicon tetrachloride and hydrogen are mixed and combusted in air at a temperature range of 1000 ° C. to 1200 ° C., and fine particulate silicic acid can be produced. . The heating method is a method in which SiO vapor generated by heating and reducing silica sand and coke in an arc furnace is oxidized with oxygen in the air, and fine particulate silicic acid can be produced.

無水ケイ酸は、適宜製造してもよく、市販品を使用してもよい。市販品としては、例えば、商品名「Aerosil」(DEGUSSA社製、又は、日本アエロジル社製)、商品名「Cab−O−Sil」(Cabot社製)等の燃焼法により製造された無水ケイ酸が挙げられ、例えば、商品名「Fransil」(Fransil社製)、商品名「Arc Silica」(PPG Inc社製)等の加熱法により製造された無水ケイ酸が挙げられる。   Silicic anhydride may be produced as appropriate, or a commercially available product may be used. Examples of commercially available products include silicic anhydride produced by a combustion method such as trade name “Aerosil” (manufactured by DEGUSSA or Nippon Aerosil Co., Ltd.) and trade name “Cab-O-Sil” (manufactured by Cabot). Examples thereof include silicic acid anhydride produced by a heating method such as a trade name “Fransil” (manufactured by Fransil), a trade name “Arc Silica” (manufactured by PPG Inc), and the like.

無水ケイ酸は、一種がゴム組成物に含有されてもよく、また、二種以上がゴム組成物に含有されてもよい。   One kind of silicic acid anhydride may be contained in the rubber composition, and two or more kinds may be contained in the rubber composition.

無水ケイ酸は、前記シリコーンゴム100質量部に対して、20質量部以上45質量部以下の割合で含有されているのが好ましく、30質量部以上45質量部以下の割合で含有されているのが特に好ましい。無水ケイ酸が前記範囲の割合でゴム組成物に含有されていると、医療用ゴム部材としたときに、医療用ゴム部材の物性等が放射線照射によって大きく低下することを効果的に防止することができる。   Silica anhydride is preferably contained in a proportion of 20 to 45 parts by mass with respect to 100 parts by mass of the silicone rubber, and contained in a proportion of 30 to 45 parts by mass. Is particularly preferred. When silicic anhydride is contained in the rubber composition in the above-mentioned range, when a medical rubber member is used, the physical properties of the medical rubber member and the like are effectively prevented from being significantly reduced by radiation irradiation. Can do.

ゴム組成物は、前記無水ケイ酸及び前記シリコーンゴムの他に、例えば、ゴムを含有する組成物に通常配合される各種添加剤等を含有していてもよい。具体的な各種添加剤としては、例えば、架橋剤、充填材、紫外線吸収剤、可塑剤、着色剤、帯電防止剤、熱安定化剤、抗酸化剤、光安定剤、難燃剤、滑剤、酸化防止剤、老化防止剤、反応助剤、反応抑制剤、樹脂等が挙げられる。前記架橋剤としては、シリコーンゴムに架橋を生じさせるラジカル反応、付加反応、縮合反応等を利用して、シリコーンゴムを加硫、硬化させるものであれば、その硬化機構に制限はなく、従来公知の種々の架橋剤(硬化剤とも称する。)を用いることができる。架橋剤として、例えば、ジ−t−ブチルパーオキサイド、2,5−ジメチル−2,5−ジ(t−ブチルパーオキシ)ヘキサン等のアルキル過酸化物、ジクミルパーオキサイド等のアルキル過酸化物等の有機過酸化物が挙げられ、架橋剤の一種である付加反応硬化剤として、例えば、ケイ素原子に結合した水素原子を一分子中に少なくとも2個以上含有するオルガノハイドロジェンポリシロキサンと白金系触媒との組み合わせ等が挙げられ、また、架橋剤の一種である縮合硬化剤として、例えば、多官能のアルコキシシラン又はシロキサンと有機金属酸塩との組み合わせ等が挙げられる。架橋剤の配合量は、シリコーンゴムに対して通常選択される配合量の範囲内から選択される。前記架橋剤を除く前記各種添加剤は公知のものを特に制限されずに用いることができる。   In addition to the silicic anhydride and the silicone rubber, the rubber composition may contain, for example, various additives that are usually blended in a rubber-containing composition. Specific examples of various additives include, for example, a crosslinking agent, a filler, an ultraviolet absorber, a plasticizer, a colorant, an antistatic agent, a heat stabilizer, an antioxidant, a light stabilizer, a flame retardant, a lubricant, and an oxidation agent. Examples thereof include an inhibitor, an antiaging agent, a reaction aid, a reaction inhibitor, and a resin. As the crosslinking agent, there is no limitation on the curing mechanism as long as it vulcanizes and cures the silicone rubber by using radical reaction, addition reaction, condensation reaction, etc. that cause crosslinking in the silicone rubber. Various crosslinking agents (also referred to as curing agents) can be used. Examples of the crosslinking agent include alkyl peroxides such as di-t-butyl peroxide, 2,5-dimethyl-2,5-di (t-butylperoxy) hexane, and alkyl peroxides such as dicumyl peroxide. As an addition reaction curing agent that is a kind of crosslinking agent, for example, an organohydrogenpolysiloxane containing at least two hydrogen atoms bonded to a silicon atom in one molecule and a platinum series Examples include a combination with a catalyst, and examples of the condensation curing agent which is a kind of a crosslinking agent include a combination of a polyfunctional alkoxysilane or siloxane and an organometallic acid salt. The blending amount of the cross-linking agent is selected from the range of blending amounts normally selected for silicone rubber. The various additives other than the crosslinking agent can be used without particular limitation.

前記ゴム組成物は、無水ケイ酸と、シリコーンゴムと、所望により各種添加剤とを、例えば、ミキシングロール、加圧式ニーダー、ローラミル、バンバリーミキサ、二本ロール、三本ロール、ホモジナイザー、ボールミル及びビーズミル等の混合機を用いて、無水ケイ酸とシリコーンゴムと各種添加剤とが均一に混合されるまで、常温又は加熱下で混練して、得られる。ゴム組成物は、適宜製造してもよく、また、市販品を使用してもよい。   The rubber composition comprises silicic anhydride, silicone rubber, and various additives as required, for example, a mixing roll, a pressure kneader, a roller mill, a Banbury mixer, a two roll, a three roll, a homogenizer, a ball mill, and a bead mill. Etc., and kneading at room temperature or under heating until the silicic anhydride, silicone rubber and various additives are uniformly mixed. The rubber composition may be produced as appropriate, or a commercially available product may be used.

この発明に係るゴム組成物は、前記したように、放射線滅菌処理において、γ線等の放射線が照射されても、物性等の変化が小さいから、医療用ゴム部材、特に、放射線滅菌処理され、注射針が刺される医療用ゴム部材を製造するのに、好適に用いられる。   As described above, the rubber composition according to the present invention is a medical rubber member, in particular, radiation sterilization treatment, because the change in physical properties and the like is small even when irradiated with radiation such as γ rays in the radiation sterilization treatment, It is suitably used for producing a medical rubber member to be pierced with an injection needle.

次に、この発明に係る医療用ゴム部材を説明する。この発明に係る医療用ゴム部材は、医療機器に装着されるゴム部材であればよく、例えば、薬液瓶の薬液注入口を閉塞する医療用ゴムボタン又は医療用ゴムキャップ、血液回路等における配管又は混注管に設けられる医療用ゴムボタン又は医療用ゴムキャップ等、さらに、これらの医療用ゴムボタン又は医療用ゴムキャップ等であって、注射針等が刺される針刺栓等が挙げられる。この発明において、注射針は、薬剤若しくは血液等を抽出若しくは注入する針であればよく、例えば、注射器に装着される針、患者の体内等に少なくともその一部が留置される留置針、又は、血液バッグ若しくは輸液バッグに装着される針等が挙げられる。   Next, the medical rubber member according to the present invention will be described. The medical rubber member according to the present invention may be a rubber member that is attached to a medical device. For example, a medical rubber button or a medical rubber cap that closes a chemical liquid injection port of a chemical liquid bottle, a pipe in a blood circuit, or the like Examples thereof include a medical rubber button or a medical rubber cap provided in the mixed injection tube, and further a needle piercing plug or the like which is a medical rubber button or medical rubber cap or the like and is inserted with an injection needle or the like. In this invention, the injection needle may be any needle that extracts or injects a drug or blood, for example, a needle attached to a syringe, an indwelling needle at least part of which is indwelled in a patient's body, or the like, or Examples thereof include a needle attached to a blood bag or an infusion bag.

医療用ゴム部材は、装着される医療機器(例えば、薬液瓶又は混注管)、特に、医療機器の装着部(例えば、薬液注入口又は薬液注入部)の形状及び寸法に応じて、任意の形状に成形され、任意の寸法に調整される。   The medical rubber member may have any shape depending on the shape and size of the medical device (for example, a chemical solution bottle or a mixed injection tube) to be mounted, in particular, a mounting portion (for example, a chemical solution inlet or a chemical solution injection portion) of the medical device. And adjusted to an arbitrary size.

この医療用ゴム部材は、100質量部のシリコーンゴムと20質量部以上45質量部以下の無水ケイ酸とを含有する前記ゴム組成物を用いて製造され、例えば、100質量部のシリコーンゴムと20質量部以上45質量部以下の無水ケイ酸とを含有する前記ゴム組成物を成形して製造される。ゴム組成物を成形する方法は、特に限定されず、公知の成形方法、例えば、押出成形、射出成形、注型成形等の成形方法等が挙げられる。医療用ゴム部材が無水ケイ酸を含有するゴム組成物で形成されると、γ線等の放射線を照射しても、物性等が大きく変化を防止することができ、医療用ゴム部材が劣化しにくくなる。   This medical rubber member is manufactured using the rubber composition containing 100 parts by mass of silicone rubber and 20 parts by mass or more and 45 parts by mass or less of silicic anhydride. For example, 100 parts by mass of silicone rubber and 20 parts by mass Manufactured by molding the rubber composition containing not less than 45 parts by mass and not more than 45 parts by mass of silicic anhydride. The method for molding the rubber composition is not particularly limited, and examples thereof include known molding methods, for example, molding methods such as extrusion molding, injection molding, and cast molding. When the medical rubber member is formed of a rubber composition containing silicic anhydride, even if irradiated with radiation such as γ rays, the physical properties can be largely prevented from changing, and the medical rubber member deteriorates. It becomes difficult.

したがって、この発明に係る医療用ゴム部材は、シリコーンゴムと無水ケイ酸とを含有している。医療用ゴム部材に含有されるシリコーンゴムは前記ゴム組成物に含有されるシリコーンゴムと同様のシリコーンゴム又はこのシリコーンゴム同士が架橋したより高分子量のシリコーンゴムである。医療用ゴム部材に含有される無水ケイ酸は前記ゴム組成物に含有される無水ケイ酸と同様の無水ケイ酸である。なお、この発明に係る医療用ゴム部材においては、シリコーンゴムと無水ケイ酸とはそれぞれ独立に含有されていてもよく、また、これらの凝集体又は複合体等として含有されていてもよい。   Therefore, the medical rubber member according to the present invention contains silicone rubber and silicic anhydride. The silicone rubber contained in the medical rubber member is a silicone rubber similar to the silicone rubber contained in the rubber composition or a higher molecular weight silicone rubber in which the silicone rubbers are crosslinked. The silicic acid anhydride contained in the medical rubber member is silicic acid anhydride similar to the silicic acid anhydride contained in the rubber composition. In the medical rubber member according to the present invention, silicone rubber and silicic anhydride may be contained independently of each other, or may be contained as aggregates or composites thereof.

この発明に係る医療用ゴム部材は、JIS A硬度が25以上40以下であるのが好ましく、30以上35以下であるのが特に好ましい。医療用ゴム部材が前記範囲のJIS A硬度を有すると、シール性が向上し、また、注射針を抜き刺しするときの医療用ゴム部材の一部が欠落及び/又は脱落することを大幅に低減することができる。JIS A硬度は、JIS K6249に規定された測定方法により、測定することができる。   The medical rubber member according to the present invention preferably has a JIS A hardness of 25 or more and 40 or less, and particularly preferably 30 or more and 35 or less. When the medical rubber member has the JIS A hardness in the above range, the sealing performance is improved, and a part of the medical rubber member is missing and / or dropped when the needle is inserted and pierced. can do. The JIS A hardness can be measured by a measuring method defined in JIS K6249.

この発明に係る医療用ゴム部材は、引裂き強度が25kN/m以上35kN/m以下であるのが好ましく、26kN/m以上33kN/m以下であるのが特に好ましい。医療用ゴム部材が前記範囲の引裂き強度を有すると、注射針を抜き刺しするときの医療用ゴム部材の一部が欠落及び/又は脱落することを大幅に低減することができる。引裂き強度は、JIS K6249に規定された測定方法(クレセント型)に規定された測定方法により、測定することができる。   The medical rubber member according to the present invention preferably has a tear strength of 25 kN / m or more and 35 kN / m or less, particularly preferably 26 kN / m or more and 33 kN / m or less. When the medical rubber member has a tear strength in the above range, it is possible to greatly reduce the loss and / or dropout of a part of the medical rubber member when the needle is inserted and punctured. The tear strength can be measured by a measurement method defined in a measurement method (crescent type) defined in JIS K6249.

この発明に係る医療用ゴム部材は、前記成形方法によって所望の形状に製造された後、及び/又は、使用前に、γ線等の放射線を照射する放射線滅菌処理が施される。放射線滅菌処理は、常法により行えばよく、医療用ゴム部材を十分に滅菌するには、例えば、γ線等の放射線を20kGy以上50kGy以下の照射量で照射すればよい。 The medical rubber member according to the present invention is subjected to a radiation sterilization treatment for irradiating radiation such as γ rays after being manufactured into a desired shape by the molding method and / or before use. The radiation sterilization treatment may be performed by a conventional method. In order to sufficiently sterilize the medical rubber member, for example, radiation such as γ rays may be irradiated at an irradiation dose of 20 kGy or more and 50 kGy or less.

このようにして放射線滅菌処理された医療用ゴム部材、すなわち、この発明に係る滅菌済医療用ゴム部材は、無水ケイ酸とシリコーンゴムとを含有し、放射線滅菌処理前の医療用ゴム部材における物性に比して、その物性の低下割合が小さい。例えば、50kGyの照射量でγ線を照射した滅菌済医療用ゴム部材のJIS A硬度は、放射線滅菌処理前の医療用ゴム部材のJIS A硬度に対する変化率が0%程度以上25%程度以下の範囲であり、好ましくは0%程度以上20%程度以下の範囲であり、特に好ましくは0%程度以上15%程度以下の範囲である。また、50kGyの照射量でγ線を照射した滅菌済医療用ゴム部材の引張強度は、放射線滅菌処理前の医療用ゴム部材の引張強度に対する変化率が−10%程度以上0%程度以下の範囲であり、好ましくは−8%程度以上0%程度以下の範囲である。50kGyの照射量でγ線を照射した滅菌済医療用ゴム部材の伸びは、放射線滅菌処理前の医療用ゴム部材の伸びに対する変化率が−30%程度以上0%程度以下の範囲である。さらに、50kGyの照射量でγ線を照射した滅菌済医療用ゴム部材の引裂き強度は、放射線滅菌処理前の医療用ゴム部材の引裂き強度に対する変化率が−25%程度以上0%程度以下の範囲であり、好ましくは−20%程度以上0%程度以下の範囲であり、特に好ましくは−17%程度以上0%程度以下の範囲である。ここで、JIS A硬度及び引裂き強度は前記方法により測定することができ、引張強度及び伸びはJIS K6249に規定された測定方法に規定された測定方法により、測定することができる。 The medical rubber member thus subjected to radiation sterilization treatment, that is, the sterilized medical rubber member according to the present invention contains anhydrous silicic acid and silicone rubber, and has physical properties in the medical rubber member before radiation sterilization treatment. Compared to the above, the rate of decrease in physical properties is small. For example, the JIS A hardness of a sterilized medical rubber member irradiated with γ rays at an irradiation dose of 50 kGy has a rate of change of about 0% or more and about 25% or less with respect to the JIS A hardness of the medical rubber member before radiation sterilization treatment. The range is preferably about 0% to about 20%, and particularly preferably about 0% to about 15%. Further, the tensile strength of the sterilized medical rubber member irradiated with γ rays at an irradiation dose of 50 kGy is such that the rate of change with respect to the tensile strength of the medical rubber member before the radiation sterilization treatment is about −10% or more and about 0% or less. It is a range, Preferably it is the range of about -8% or more and about 0% or less. The elongation of the sterilized medical rubber member irradiated with γ-rays at an irradiation dose of 50 kGy is in a range where the rate of change relative to the elongation of the medical rubber member before the radiation sterilization treatment is about −30% to about 0%. Furthermore, the tear strength of the sterilized medical rubber member irradiated with γ rays at an irradiation dose of 50 kGy is such that the rate of change with respect to the tear strength of the medical rubber member before the radiation sterilization treatment is about −25% to about 0%. The range is preferably about −20% or more and about 0% or less, and particularly preferably about −17% or more and about 0% or less. Here, JIS A hardness and tear strength can be measured by the above methods, and tensile strength and elongation can be measured by the measurement methods defined in the measurement method defined in JIS K6249.

この発明に係る医療用ゴム部材は、無水ケイ酸とシリコーンゴムとを含有するゴム組成物を成形して成るから、放射線滅菌処理において、γ線等の放射線を照射しても、その物性等が大きく変化することはなく、劣化しにくい。その理由の1つとして、例えば、前記したように、無水ケイ酸が医療用ゴム部材の表面全体を覆っていなくても、医療用ゴム部材に含有される無水ケイ酸によって、放射線照射によるシリコーンゴムの分解を抑えて、耐放射線性が向上することが考えられる。その結果、この発明に係る医療用ゴム部材は、放射線滅菌処理されても、すなわち、この発明に係る滅菌済医療用ゴム部材は、医療用ゴム部材における亀裂等の発生を防止することができると共に、薬液の滲出、薬液の汚染防止等の医療用ゴム部材に要求される機能を十分に維持することができる。   Since the medical rubber member according to the present invention is formed by molding a rubber composition containing silicic anhydride and silicone rubber, the physical properties and the like of the medical rubber member can be obtained even when irradiated with radiation such as γ rays in radiation sterilization treatment. It does not change significantly and is not easily degraded. As one of the reasons, for example, as described above, even if silicic anhydride does not cover the entire surface of the medical rubber member, the silicone rubber by radiation irradiation can be used with the silicic acid contained in the medical rubber member. It is conceivable that the radiation resistance is improved by suppressing the decomposition of. As a result, even when the medical rubber member according to the present invention is subjected to radiation sterilization treatment, that is, the sterilized medical rubber member according to the present invention can prevent the occurrence of cracks and the like in the medical rubber member. The functions required of the medical rubber member such as the exudation of the chemical solution and the prevention of the contamination of the chemical solution can be sufficiently maintained.

この発明に係る医療用ゴム部材が針刺栓として使用される場合には、医療用ゴム部材は、放射線滅菌処理されても、劣化しにくい特性に加えて、抜き刺しされる注射針によって、医療用ゴム部材の一部が医療用ゴム部材から欠落、脱落又は剥離することを防止することができる。その結果、この発明に係る医療用ゴム部材は、放射線滅菌処理されても、すなわち、この発明に係る滅菌済医療用ゴム部材は、必要量の薬液を薬液瓶から取り出した後にも、薬液瓶に収容された薬液を密封した状態を維持して、薬液の滲出及び薬液の汚染等を防止するという目的を達成することができる。   When the medical rubber member according to the present invention is used as a needle puncture plug, the medical rubber member has a characteristic that it is difficult to deteriorate even when subjected to radiation sterilization treatment. It is possible to prevent a part of the medical rubber member from being lost, dropped off or peeled off from the medical rubber member. As a result, even if the medical rubber member according to the present invention is subjected to radiation sterilization treatment, that is, the sterilized medical rubber member according to the present invention can be placed in the chemical solution bottle even after the necessary amount of chemical solution is taken out from the chemical solution bottle. It is possible to achieve the object of maintaining the sealed state of the stored chemical solution and preventing the chemical solution from exuding and chemical solution contamination.

また、この発明に係る医療用ゴム部材は、このように、γ線等の放射線を照射しても、劣化しにくいから、例えば、ゴム組成物の成形後及び使用前等に、放射線滅菌処理を複数回行うことができる。   In addition, since the medical rubber member according to the present invention is not easily deteriorated even when irradiated with radiation such as γ-rays in this way, for example, radiation sterilization treatment is performed after molding of the rubber composition and before use. Can be done multiple times.

この発明に係る医療用ゴム部材の一実施例を、図面を用いて、説明する。医療用ゴム部材の一実施例は、図1及び図2に示されるように、薬液瓶30等の薬液注入口31等を閉塞する医療用ゴムキャップ1である。医療用ゴムキャップ1は、薬液瓶30の薬液注入口31に圧入されて薬液注入口31を閉塞するゴムキャップ本体10と、ゴムキャップ本体10の上部に円周方向に突出した頭部11とを備えてなり、注射針20が貫通する針刺栓の一例である。この医療用ゴムキャップ1におけるゴムキャップ本体10は、装着される薬液瓶30における薬液注入口31の断面形状に応じて円筒状に形成され、その径は薬液注入口31の内径よりもわずかに大きな寸法に調整されている。医療用ゴムキャップ1における頭部11は、円盤状に形成され、その径は薬液瓶30における薬液注入口31に設けられた鍔部32の外径とほぼ同じ寸法に調整されている。   An embodiment of a medical rubber member according to the present invention will be described with reference to the drawings. One embodiment of the medical rubber member is a medical rubber cap 1 that closes a chemical liquid injection port 31 such as a chemical liquid bottle 30 as shown in FIGS. 1 and 2. The medical rubber cap 1 includes a rubber cap main body 10 that is press-fitted into a chemical liquid injection port 31 of the chemical liquid bottle 30 to close the chemical liquid injection port 31, and a head 11 that protrudes in the circumferential direction on the upper part of the rubber cap main body 10. This is an example of a needle pierce that is provided and through which the injection needle 20 penetrates. The rubber cap body 10 in the medical rubber cap 1 is formed in a cylindrical shape according to the cross-sectional shape of the chemical liquid inlet 31 in the chemical liquid bottle 30 to be attached, and the diameter thereof is slightly larger than the inner diameter of the chemical liquid inlet 31. The dimensions have been adjusted. The head 11 in the medical rubber cap 1 is formed in a disk shape, and the diameter thereof is adjusted to be approximately the same as the outer diameter of the collar portion 32 provided in the chemical liquid inlet 31 in the chemical liquid bottle 30.

この医療用ゴムキャップ1は、無水ケイ酸とシリコーンゴムとを含有する前記ゴム組成物を射出成形して成り、それぞれ一種又は二種以上の無水ケイ酸及びシリコーンゴムを含有している。医療用ゴムキャップ1は、JIS A硬度が30以上35以下に調整されている。医療用ゴムキャップ1は、使用前に、例えば、γ線が照射量22.2kGyで照射され、滅菌済医療用ゴムキャップ2とされる。この滅菌済医療用ゴムキャップ2は、前記したように、その物性が医療用ゴムキャップ1の物性に対して大きく変化することはなく、例えば、50kGyの照射量でγ線を照射して滅菌しても、JIS A硬度、引張強度、伸び及び引裂き強度は、前記した範囲内にある。 This medical rubber cap 1 is formed by injection-molding the rubber composition containing anhydrous silicic acid and silicone rubber, and each contains one or more kinds of anhydrous silicic acid and silicone rubber. The medical rubber cap 1 has a JIS A hardness of 30 to 35. Prior to use, the medical rubber cap 1 is irradiated with, for example, γ rays at an irradiation amount of 22.2 kGy to form a sterilized medical rubber cap 2. As described above, the sterilized medical rubber cap 2 does not greatly change its physical properties with respect to the physical properties of the medical rubber cap 1. For example, the sterilized medical rubber cap 2 is sterilized by irradiating γ rays with an irradiation dose of 50 kGy. Even so, the JIS A hardness, tensile strength, elongation and tear strength are within the above-mentioned ranges.

医療用ゴムキャップ1が滅菌処理されて成る滅菌済医療用ゴムキャップ2は、図2に示されるように、薬液瓶30の薬液注入口31にゴムキャップ本体10が、薬液注入口31の鍔部32と頭部11の底面とが当接するまで、圧入されて、薬液瓶30に装着される。そして、薬液瓶30に収納された薬液33を取り出す際には、図2に示されるように、滅菌済医療用ゴムキャップ2に注射針20を刺して、注射針20を滅菌済医療用ゴムキャップ2に貫通させ、例えば、薬液瓶30を傾斜又は転倒させて、注射針20から薬液33を抽出する。その後、注射針20を滅菌済医療用ゴムキャップ2から抜き取る。このようにして一連の動作が終了するが、医療用ゴムキャップ1は無水ケイ酸とシリコーンゴムとを含有するゴム組成物を成形して成るから、放射線滅菌処理されても劣化せず、また、劣化しにくい。したがって、医療用ゴムキャップ1の使用前に放射線滅菌処理されて成る滅菌済医療用ゴムキャップ2は、その物性が医療用ゴムキャップ1に対して大きく変化することはないから、滅菌済医療用ゴムキャップ2における亀裂の発生等を防止することができると共に、滅菌済医療用ゴムキャップ2に注射針20を容易に貫通させることができ、薬液33の滲出及び薬液33の汚染等を避けて必要量の薬液33を取り出すことができる。   As shown in FIG. 2, the sterilized medical rubber cap 2 obtained by sterilizing the medical rubber cap 1 has the rubber cap body 10 at the chemical liquid injection port 31 of the chemical liquid bottle 30 and the buttocks of the chemical liquid injection port 31. It press-fits until 32 and the bottom face of the head 11 contact | abut, and is mounted | worn with the chemical | medical solution bottle 30. FIG. And when taking out the chemical | medical solution 33 accommodated in the chemical | medical solution bottle 30, as shown in FIG. 2, the injection needle 20 is stabbed into the sterilized medical rubber cap 2, and the injection needle 20 is sterilized medical rubber cap. 2, for example, the drug solution bottle 30 is tilted or overturned, and the drug solution 33 is extracted from the injection needle 20. Thereafter, the injection needle 20 is removed from the sterilized medical rubber cap 2. In this way, a series of operations are completed, but the medical rubber cap 1 is formed by molding a rubber composition containing anhydrous silicic acid and silicone rubber, so that it does not deteriorate even when subjected to radiation sterilization treatment. Hard to deteriorate. Accordingly, the sterilized medical rubber cap 2 that has been sterilized by radiation before use of the medical rubber cap 1 does not greatly change its physical properties relative to the medical rubber cap 1. In addition to preventing cracks in the cap 2 and the like, the injection needle 20 can be easily passed through the sterilized medical rubber cap 2, and the necessary amount is avoided while exuding the drug solution 33 and contaminating the drug solution 33. The chemical solution 33 can be taken out.

さらに、滅菌済医療用ゴムキャップ2は、注射針20を刺しても、滅菌済医療用ゴムキャップ2の一部が滅菌済医療用ゴムキャップ2から欠落、脱落又は剥離することを防止することができるから、必要量の薬液33を薬液瓶30から取り出した後にも、薬液瓶30に収容された薬液33を密封した状態を維持して、薬液33の滲出及び薬液33の汚染等を防止するという目的を達成することができる。   Furthermore, the sterilized medical rubber cap 2 can prevent a part of the sterilized medical rubber cap 2 from being lost, dropped off, or peeled off from the sterilized medical rubber cap 2 even if the injection needle 20 is inserted. Therefore, even after the required amount of the chemical solution 33 is taken out from the chemical solution bottle 30, the state in which the chemical solution 33 contained in the chemical solution bottle 30 is kept sealed prevents exudation of the chemical solution 33, contamination of the chemical solution 33, and the like. Aim can be achieved.

また、医療用ゴムキャップ1及び滅菌済医療用ゴムキャップ2は、放射線滅菌処理を複数回行うことができる。   Further, the medical rubber cap 1 and the sterilized medical rubber cap 2 can be subjected to radiation sterilization multiple times.

この発明に係る医療用ゴム部材の別の一実施例を、図面を用いて、説明する。医療用ゴム部材の別の一実施例は、図3及び図4に示されるように、混注管40等の薬液注入部43等を閉塞する医療用ゴムボタン3である。医療用ゴムボタン3は、例えば、人工心臓等の血液回路の一部を構成する配管41及び42に介装された混注管40に装着される医療用ゴムキャップであり、混注管40における三方分岐部の薬液注入部43に圧入されて薬液注入部43を閉塞し、注射針20が貫通する針刺栓の一例である。この医療用ゴムボタン3は、装着される混注管40における薬液注入部43の断面形状に応じて円盤状に形成され、その径は装着される混注管40における薬液注入部43の内径よりもわずかに大きな寸法に調整されている。   Another embodiment of the medical rubber member according to the present invention will be described with reference to the drawings. Another embodiment of the medical rubber member is a medical rubber button 3 that closes the drug solution injection portion 43 such as the mixed injection tube 40 as shown in FIGS. 3 and 4. The medical rubber button 3 is, for example, a medical rubber cap that is attached to a mixed injection tube 40 interposed in pipes 41 and 42 that constitute a part of a blood circuit such as an artificial heart. This is an example of a needle puncture needle that is press-fitted into the chemical liquid injection part 43 of the part to close the chemical liquid injection part 43 and through which the injection needle 20 passes. This medical rubber button 3 is formed in a disc shape according to the cross-sectional shape of the chemical injection part 43 in the mixed injection tube 40 to be attached, and its diameter is slightly smaller than the inner diameter of the chemical injection part 43 in the mixed injection pipe 40 to be attached. It has been adjusted to a large size.

この医療用ゴムボタン3は、無水ケイ酸とシリコーンゴムとを含有する前記ゴム組成物を射出成形して成り、それぞれ一種又は二種以上の無水ケイ酸及びシリコーンゴムを含有している。医療用ゴムボタン3は、JIS A硬度が30以上35以下に調整されている。医療用ゴムボタン3は、使用前に、例えば、γ線が照射量22.2kGyで照射され、滅菌済医療用ゴムボタン4とされる。この滅菌済医療用ゴムボタン4は、前記したように、その物性が医療用ゴムボタン3の物性に対して大きく変化することはなく、例えば、50kGyの照射量でγ線を照射して滅菌しても、JIS A硬度、引張強度、伸び及び引裂き強度は、前記した範囲内にある。 This medical rubber button 3 is formed by injection molding the rubber composition containing anhydrous silicic acid and silicone rubber, and each contains one or more kinds of anhydrous silicic acid and silicone rubber. The medical rubber button 3 has a JIS A hardness adjusted to 30 or more and 35 or less. Prior to use, the medical rubber button 3 is irradiated with, for example, γ rays at an irradiation amount of 22.2 kGy to form a sterilized medical rubber button 4. As described above, the sterilized medical rubber button 4 does not greatly change its physical property with respect to the physical property of the medical rubber button 3. For example, the sterilized medical rubber button 4 is sterilized by irradiating γ rays with an irradiation dose of 50 kGy. Even so, the JIS A hardness, tensile strength, elongation and tear strength are within the above-mentioned ranges.

医療用ゴムボタン3が滅菌処理されて成る滅菌済医療用ゴムボタン4は、図4に示されるように、混注管40の薬液注入部43に圧入されて、混注管40に装着される。そして、混注管40に薬液(図示しない。)等を注入又は混注管40を流通する体液等を抽出する際には、図4に示されるように、滅菌済医療用ゴムボタン4に注射針20を刺して、注射針20を滅菌済医療用ゴムボタン4に貫通させ、注射針20から混注管40の薬液注入部43に薬液等を注入又は混注管40を流通する体液等を抽出等する。その後、注射針20を滅菌済医療用ゴムボタン4から抜き取る。このようにして一連の動作が終了するが、医療用ゴムボタン3は無水ケイ酸とシリコーンゴムとを含有するゴム組成物を成形して成るから、放射線滅菌処理されても劣化せず、また、劣化しにくい。したがって、医療用ゴムボタン3の使用前に放射線滅菌処理されて成る滅菌済医療用ゴムボタン4は、その物性が医療用ゴムボタン3に対して大きく変化することはないから、滅菌済医療用ゴムボタン4における亀裂の発生等を防止することができると共に、滅菌済医療用ゴムボタン4に注射針20を容易に貫通させることができ、混注管40を流通する血液等の滲出及び汚染等を避けて必要な薬液等を混注管40に注入又は混注管40を流通する体液等を抽出することができる。   As shown in FIG. 4, the sterilized medical rubber button 4 obtained by sterilizing the medical rubber button 3 is press-fitted into the drug solution injection portion 43 of the mixed injection tube 40 and attached to the mixed injection tube 40. When injecting a chemical solution (not shown) or the like into the mixed injection tube 40 or extracting a body fluid or the like flowing through the mixed injection tube 40, as shown in FIG. Is inserted into the sterilized medical rubber button 4 to inject a drug solution or the like from the injection needle 20 into the drug solution injection portion 43 of the mixed injection tube 40 or extract a body fluid or the like flowing through the mixed injection tube 40. Thereafter, the injection needle 20 is removed from the sterilized medical rubber button 4. In this way, a series of operations are completed, but the medical rubber button 3 is formed by molding a rubber composition containing anhydrous silicic acid and silicone rubber, so that it does not deteriorate even when subjected to radiation sterilization treatment. Hard to deteriorate. Accordingly, the sterilized medical rubber button 4 that has been subjected to radiation sterilization treatment before the use of the medical rubber button 3 does not greatly change its physical properties relative to the medical rubber button 3. The button 4 can be prevented from cracking and the like, and the syringe needle 20 can be easily penetrated through the sterilized medical rubber button 4 to avoid exudation and contamination of blood flowing through the mixed injection tube 40. Therefore, a necessary body fluid or the like can be injected into the mixed injection tube 40 or a body fluid flowing through the mixed injection tube 40 can be extracted.

さらに、滅菌済医療用ゴムボタン4は、注射針20を刺しても、滅菌済医療用ゴムボタン4の一部が滅菌済医療用ゴムボタン4から欠落、脱落又は剥離することを防止することができるから、必要な薬液等を混注管40に注入又は混注管40を流通する体液等を抽出した後にも、混注管40を流通する血液等を密封した状態を維持して、混注管40を流通する血液等の滲出及び汚染等を防止するという目的を達成することができる。   Further, the sterilized medical rubber button 4 can prevent a part of the sterilized medical rubber button 4 from being lost, dropped off, or peeled off from the sterilized medical rubber button 4 even if the injection needle 20 is inserted. Therefore, even after injecting the necessary medicinal solution into the mixed injection tube 40 or extracting the body fluid flowing through the mixed injection tube 40, the blood flowing through the mixed injection tube 40 is maintained sealed and distributed through the mixed injection tube 40. The purpose of preventing exudation and contamination of blood and the like can be achieved.

また、医療用ゴムボタン3及び滅菌済医療用ゴムボタン4は、放射線滅菌処理を複数回行うことができる。   Further, the medical rubber button 3 and the sterilized medical rubber button 4 can be subjected to radiation sterilization processing a plurality of times.

この発明における医療用ゴム部材は、前記した実施例に限定されることはなく、本願発明の目的を達成することができる範囲において、種々の変更が可能である。例えば、前記医療用ゴムキャップ1及び医療用ゴムボタン3は円筒状又は円盤状に成形されているが、この発明において、医療用ゴム部材は、円筒状又は円盤状に限定されることなく、例えば、矩形、多角形又は流線形等の形状に成形されてもよい。   The medical rubber member according to the present invention is not limited to the above-described embodiments, and various modifications can be made within a range in which the object of the present invention can be achieved. For example, the medical rubber cap 1 and the medical rubber button 3 are formed in a cylindrical shape or a disk shape, but in the present invention, the medical rubber member is not limited to a cylindrical shape or a disk shape, The shape may be a rectangle, a polygon, a streamline, or the like.

前記医療用ゴムキャップ1及び滅菌済医療用ゴムキャップ2は、ゴムキャップ本体10と頭部11とを備えているが、この発明において、医療用ゴムキャップ及び滅菌済医療用ゴムキャップは頭部を有しないゴムキャップ本体で構成されてもよい。また、前記医療用ゴムボタン3及び滅菌済医療用ゴムボタン4は円盤状に成形されているが、この発明において、医療用ゴムボタン及び滅菌済医療用ゴムボタンはその上部に円周方向に突出する頭部と備えていてもよい。   The medical rubber cap 1 and the sterilized medical rubber cap 2 include a rubber cap body 10 and a head portion 11. In the present invention, the medical rubber cap and the sterilized medical rubber cap have a head portion. You may comprise with the rubber cap main body which does not have. The medical rubber button 3 and the sterilized medical rubber button 4 are formed in a disc shape. In the present invention, the medical rubber button and the sterilized medical rubber button protrude in the circumferential direction on the upper part. You may be equipped with the head to do.

前記医療用ゴムキャップ1、滅菌済医療用ゴムキャップ2、医療用ゴムボタン3及び滅菌済医療用ゴムボタン4はいずれも、注射針等が刺される針刺栓であるが、この発明において、医療用ゴム部材は、薬液瓶の薬液注入口又は人工心臓等の血液回路若しくは人工透析等の体液回路等における混注管の薬液注入部を単に閉塞する栓であってもよく、また、注射針等が刺されない、すなわち、ニードレスタイプの医療用ゴム部材であってもよい。ニードレスタイプの医療用ゴム部材は、軸線方向に貫通し、薬剤の取出し及び注入を可能にするスリットを備えて成る、例えば、薬液瓶の薬液注入口を閉塞する医療用ゴムボタン又は医療用ゴムキャップ、人工心臓等の血液回路又は人工透析等の体液回路等における混注管に設けられる医療用ゴムボタン又は医療用ゴムキャップ等が挙げられる。   The medical rubber cap 1, the sterilized medical rubber cap 2, the medical rubber button 3, and the sterilized medical rubber button 4 are all needle stabs that are inserted with an injection needle or the like. The rubber member for medical use may be a stopper that simply closes the drug solution injection part of the mixed injection tube in the drug solution injection port of the drug solution bottle, the blood circuit such as an artificial heart, or the body fluid circuit such as artificial dialysis, etc. It may be a medical rubber member that is not stabbed, that is, a kneeless type. The needleless type medical rubber member is provided with a slit that penetrates in the axial direction and allows the medicine to be taken out and injected, for example, a medical rubber button or a medical rubber cap that closes the chemical liquid inlet of the chemical bottle. And a medical rubber button or a medical rubber cap provided on a mixed injection tube in a blood circuit such as an artificial heart or a body fluid circuit such as artificial dialysis.

(実施例1〜5及び比較例1〜3)
下記の組成を有するゴム組成物1〜5(実施例1〜5)及びゴム組成物6〜8(比較例1〜3)をそれぞれ射出成形して、JIS K6249に規定の「ダンベル型試験片」を複数作製した。このようにして作製した各ダンベル型試験片の一部について、その上面及び下面に照射量25kGyずつ(合計50kGy)、コバルト60より発するγ線を照射し、照射済試験片とした。ダンベル型試験片(この発明における医療用ゴム部材に相当する。)及び照射済試験片(この発明における滅菌済医療用ゴム部材に相当する。)を用いて、JIS K6249に規定の測定方法に準拠して、JIS A硬度、引張強度、伸び及び引裂き強度を測定し、照射済試験片の測定値とダンベル型試験片の測定値との差をダンベル型試験片の測定値で除して、変化率(%)を算出した。その結果を表1に示す。
(Examples 1-5 and Comparative Examples 1-3)
Rubber compositions 1 to 5 (Examples 1 to 5) and rubber compositions 6 to 8 (Comparative Examples 1 to 3) having the following compositions were respectively injection-molded, and “dumbbell-shaped test pieces” defined in JIS K6249. Several were produced. A part of each dumbbell-shaped test piece produced in this way was irradiated with γ rays emitted from cobalt 60 on the upper surface and the lower surface by a dose of 25 kGy (total 50 kGy ) to obtain irradiated test pieces. Using a dumbbell-shaped test piece (corresponding to a medical rubber member in the present invention) and an irradiated test piece (corresponding to a sterilized medical rubber member in the present invention), conforming to the measurement method prescribed in JIS K6249 JIS A hardness, tensile strength, elongation and tear strength are measured, and the difference between the measured value of the irradiated specimen and the measured value of the dumbbell specimen is divided by the measured value of the dumbbell specimen. The rate (%) was calculated. The results are shown in Table 1.

(ゴム組成物1)
メチルビニルポリシロキサン(重合度約8,000、ビニル基含有量0.25モル%)100質量部、無水ケイ酸(BET比表面積200m/g、見掛比重約50g/L、1次粒子径約12nm、商品名「アエロジル200」、日本アエロジル株式会社製)32.5質量部、2,5−ジメチル−2,5−ジ(t−ブチルパーオキシ)ヘキサン0.7質量部
(ゴム組成物2)
メチルビニルポリシロキサン(重合度約8,000、ビニル基含有量0.25モル%)100質量部、無水ケイ酸(BET比表面積110m/g、見掛比重約50g/L、1次粒子径約16nm、商品名「アエロジルR972」、日本アエロジル株式会社製)32.5質量部、2,5−ジメチル−2,5−ジ(t−ブチルパーオキシ)ヘキサン0.7質量部
(ゴム組成物3)
メチルビニルポリシロキサン(重合度約800、ビニル基含有量0.25モル%)100質量部、無水ケイ酸(BET比表面積200m/g、見掛比重約50g/L、1次粒子径約12nm、商品名「アエロジル200」、日本アエロジル株式会社製)32.5質量部、メチルハイドロジェンポリシロキサン4質量部、白金系触媒を白金換算で5ppm
(ゴム組成物4)
前記ゴム組成物1における無水ケイ酸の含有量を32.5質量部から20質量部へ変更したゴム組成物
(ゴム組成物5)
前記ゴム組成物1における無水ケイ酸の含有量を32.5質量部から45質量部へ変更したゴム組成物
(Rubber composition 1)
100 parts by mass of methyl vinyl polysiloxane (degree of polymerization about 8,000, vinyl group content 0.25 mol%), silicic anhydride (BET specific surface area 200 m 2 / g, apparent specific gravity about 50 g / L, primary particle diameter About 12 nm, trade name “Aerosil 200” manufactured by Nippon Aerosil Co., Ltd. 32.5 parts by mass, 2,5-dimethyl-2,5-di (t-butylperoxy) hexane 0.7 part by mass (rubber composition) 2)
100 parts by mass of methyl vinyl polysiloxane (degree of polymerization about 8,000, vinyl group content 0.25 mol%), silicic anhydride (BET specific surface area 110 m 2 / g, apparent specific gravity about 50 g / L, primary particle diameter About 16 nm, trade name “Aerosil R972”, manufactured by Nippon Aerosil Co., Ltd. 32.5 parts by mass, 2,5-dimethyl-2,5-di (t-butylperoxy) hexane 0.7 parts by mass (rubber composition) 3)
Methyl vinyl polysiloxane (degree of polymerization about 800, vinyl group content 0.25 mol%) 100 parts by mass, silicic anhydride (BET specific surface area 200 m 2 / g, apparent specific gravity about 50 g / L, primary particle diameter about 12 nm , Trade name "Aerosil 200", manufactured by Nippon Aerosil Co., Ltd.) 32.5 parts by mass, methyl hydrogen polysiloxane 4 parts by mass, platinum-based catalyst 5 ppm in terms of platinum
(Rubber composition 4)
Rubber composition in which content of silicic acid anhydride in rubber composition 1 is changed from 32.5 parts by mass to 20 parts by mass (rubber composition 5)
Rubber composition in which content of silicic anhydride in rubber composition 1 is changed from 32.5 parts by mass to 45 parts by mass

(ゴム組成物6)
メチルビニルポリシロキサン(重合度約8,000、ビニル基含有量0.25モル%)100質量部、含水ケイ酸(BET比表面積200m/g、二次粒子径18μm、商品名「シリカ製ニプシルVN−3」、東ソー株式会社製)42質量部、2,5−ジメチル−2,5−ジ(t−ブチルパーオキシ)ヘキサン0.7質量部
(ゴム組成物7)
前記ゴム組成物1における無水ケイ酸の含有量を32.5質量部から15質量部へ変更したゴム組成物
(ゴム組成物8)
前記ゴム組成物1における無水ケイ酸の含有量を32.5質量部から50質量部へ変更したゴム組成物
(Rubber composition 6)
100 parts by mass of methyl vinyl polysiloxane (degree of polymerization about 8,000, vinyl group content 0.25 mol%), hydrous silicic acid (BET specific surface area 200 m 2 / g, secondary particle diameter 18 μm, trade name “Nipsil made of silica” VN-3 ", manufactured by Tosoh Corporation) 42 parts by mass, 0.7 parts by mass of 2,5-dimethyl-2,5-di (t-butylperoxy) hexane (rubber composition 7)
Rubber composition wherein the content of silicic acid anhydride in the rubber composition 1 is changed from 32.5 parts by mass to 15 parts by mass (rubber composition 8)
Rubber composition in which content of silicic acid anhydride in rubber composition 1 is changed from 32.5 parts by mass to 50 parts by mass

Figure 0005013516
Figure 0005013516

(実施例6〜10及び比較例4〜6)
前記ゴム組成物1〜5(実施例6〜10)及びゴム組成物6〜8(比較例4〜6)をそれぞれ射出成形し、図1に示される形状を有する医療用ゴムキャップ1を複数製造した。このようにして製造した医療用ゴムキャップ1の一部を、照射量39.2kGyでコバルト60より発するγ線を医療用ゴムキャップ1の全面に均等に照射して、図1及び図2に示される形状を有する滅菌済医療用ゴムキャップ2を製造した。各医療用ゴムキャップ1及び各滅菌済医療用ゴムキャップ2は、外径5.5mm、長さ1.8mmのゴムキャップ本体10と、外径8.2mm、厚さ5.3mmの頭部11とを備えていた。各医療用ゴムキャップ1及び各滅菌済医療用ゴムキャップ2のゴムキャップ本体10を、図2に示されるように、薬液瓶30の薬液注入口31(内径5.2mm(ゴムキャップ本体10の外径に対して95%)、外径8.2mm)に圧入した。薬液注入口31に装着された各医療用ゴムキャップ1及び各滅菌済医療用ゴムキャップ2に、図2に示されるように、注射器の注射針(18G)20を貫通するまで刺し、次いで、刺した注射針20を引き抜いた。この注射針20の刺し及び抜きを1サイクルとして、連続して10サイクル行い、各医療用ゴムキャップ1及び各滅菌済医療用ゴムキャップ2の状態を目視で確認した。各医療用ゴムキャップ1及び各滅菌済医療用ゴムキャップ2についてこの試験を複数回行い、次のように評価した。いずれの試験においても、医療用ゴムキャップ1又は滅菌済医療用ゴムキャップ2の一部が欠落、脱落又は剥離しなかった場合を「○」、複数回の試験のうち少なくとも1回の試験において、医療用ゴムキャップ1又は滅菌済医療用ゴムキャップ2の一部が欠落、脱落又は剥離した場合を「△」、複数回の試験のうちほとんどの試験において、医療用ゴムキャップ1又は滅菌済医療用ゴムキャップ2の一部が注射針の針穴形状に欠落、脱落又は剥離した場合を「×」とした。その結果を表2に示す。

(Examples 6 to 10 and Comparative Examples 4 to 6)
The rubber compositions 1 to 5 (Examples 6 to 10) and the rubber compositions 6 to 8 (Comparative Examples 4 to 6) are respectively injection molded to produce a plurality of medical rubber caps 1 having the shape shown in FIG. did. A part of the medical rubber cap 1 manufactured in this way is evenly irradiated on the entire surface of the medical rubber cap 1 with gamma rays emitted from the cobalt 60 at an irradiation amount of 39.2 kGy . A sterilized medical rubber cap 2 having the shape shown was produced. Each medical rubber cap 1 and each sterilized medical rubber cap 2 have a rubber cap body 10 having an outer diameter of 5.5 mm and a length of 1.8 mm, and a head 11 having an outer diameter of 8.2 mm and a thickness of 5.3 mm. And had. As shown in FIG. 2, the rubber cap body 10 of each medical rubber cap 1 and each sterilized medical rubber cap 2 is connected to a chemical solution inlet 31 (inner diameter 5.2 mm (outside of the rubber cap main body 10)). The inner diameter was 95%) and the outer diameter was 8.2 mm. As shown in FIG. 2, the medical rubber caps 1 and the sterilized medical rubber caps 2 attached to the drug solution inlets 31 are pierced until they penetrate the injection needle (18G) 20 of the syringe, and then pierced. The injection needle 20 was pulled out. The injection needle 20 was stabbed and pulled out as one cycle, and 10 cycles were performed continuously, and the state of each medical rubber cap 1 and each sterilized medical rubber cap 2 was visually confirmed. This test was performed a plurality of times for each medical rubber cap 1 and each sterilized medical rubber cap 2 and evaluated as follows. In any test, when a part of the medical rubber cap 1 or the sterilized medical rubber cap 2 is missing, does not fall off or peel off, “○”, in at least one test among a plurality of tests, When a part of the medical rubber cap 1 or the sterilized medical rubber cap 2 is missing, dropped or peeled off, “△” indicates that the medical rubber cap 1 or sterilized medical use is used in most of the tests. A case where a part of the rubber cap 2 was missing, dropped or peeled off in the shape of the needle hole of the injection needle was indicated as “x”. The results are shown in Table 2.

Figure 0005013516
Figure 0005013516

図1は、この発明の一実施例である医療用ゴムキャップを示す概略斜視図である。FIG. 1 is a schematic perspective view showing a medical rubber cap according to an embodiment of the present invention. 図2は、この発明の一実施例である滅菌済医療用ゴムキャップに注射針を刺した状態を示す概略断面図である。FIG. 2 is a schematic sectional view showing a state where an injection needle is inserted into a sterilized medical rubber cap according to an embodiment of the present invention. 図3は、この発明の別の一実施例である医療用ゴムボタンを示す概略斜視図である。FIG. 3 is a schematic perspective view showing a medical rubber button according to another embodiment of the present invention. 図4は、この発明の一実施例である滅菌済医療用ゴムボタンに注射針を刺した状態を示す概略断面図である。FIG. 4 is a schematic cross-sectional view showing a state where an injection needle is inserted into a sterilized medical rubber button according to an embodiment of the present invention.

符号の説明Explanation of symbols

1 医療用ゴムキャップ
2 滅菌済医療用ゴムキャップ
3 医療用ゴムボタン
4 滅菌済医療用ゴムボタン
10 ゴムキャップ本体
11 頭部
20 注射針
30 薬液瓶
31 薬液注入口
32 鍔部
33 薬液
40 混注管
41、42 配管
43 薬液注入部
DESCRIPTION OF SYMBOLS 1 Medical rubber cap 2 Sterilized medical rubber cap 3 Medical rubber button 4 Sterilized medical rubber button 10 Rubber cap main body 11 Head 20 Injection needle 30 Medicinal solution bottle 31 Medicinal solution injection port 32 Butt portion 33 Medicinal solution 40 Mixed injection tube 41 42 Pipe 43 Chemical solution injection part

Claims (5)

100質量部のシリコーンゴムと20質量部以上45質量部以下の無水ケイ酸とを含有し、銀イオン含有無機系抗菌剤無含有のゴム組成物を成形して成る医療用ゴム部材に放射線滅菌処理を施してなる滅菌済医療用ゴムキャップ又は医療用ゴムボタンであって、
50kGyの照射量でγ線を照射する放射線滅菌処理前後における引裂き強度の変化率が−25%以上0%以下であることを特徴とする滅菌済医療用ゴムキャップ又は医療用ゴムボタン
Radiation sterilization treatment for a medical rubber member containing 100 parts by mass of silicone rubber and 20 parts by mass or more and 45 parts by mass or less of silicic acid anhydride and containing a silver ion-containing inorganic antibacterial agent-free rubber composition A sterilized medical rubber cap or a medical rubber button,
A sterilized medical rubber cap or medical rubber button characterized in that the rate of change in tear strength before and after radiation sterilization treatment in which γ rays are irradiated at an irradiation dose of 50 kGy is -25% or more and 0% or less .
前記無水ケイ酸は、少なくとも95質量%の二酸化ケイ素及び多くとも5質量%の水を含有していることを特徴とする請求項1に記載の滅菌済医療用ゴムキャップ又は医療用ゴムボタン The sterilized medical rubber cap or medical rubber button according to claim 1, wherein the silicic acid anhydride contains at least 95% by mass of silicon dioxide and at most 5% by mass of water . 前記無水ケイ酸は、一次粒子径が0.001μm以上10μm以下であることを特徴とする請求項1又は2に記載の滅菌済医療用ゴムキャップ又は医療用ゴムボタン 3. The sterilized medical rubber cap or medical rubber button according to claim 1, wherein the silicic acid anhydride has a primary particle diameter of 0.001 μm to 10 μm . 前記無水ケイ酸は、40g/L以上70g/L以下の見掛け比重を有していることを特徴とする請求項1〜3のいずれか1項に記載の滅菌済医療用ゴムキャップ又は医療用ゴムボタン The sterilized medical rubber cap or medical rubber according to any one of claims 1 to 3, wherein the silicic acid anhydride has an apparent specific gravity of 40 g / L or more and 70 g / L or less. Button . 前記ゴム組成物は、親水性付与剤としてポリエーテル変性シリコーンオイル又はカルビノール変性シリコーンオイルを含有していないことを特徴とする請求項1〜4のいずれか1項に記載の滅菌済医療用ゴムキャップ又は医療用ゴムボタン The sterilized medical rubber according to any one of claims 1 to 4, wherein the rubber composition does not contain a polyether-modified silicone oil or a carbinol-modified silicone oil as a hydrophilicity imparting agent. Cap or medical rubber button .
JP2007175724A 2007-07-04 2007-07-04 Medical rubber member, sterilized medical rubber member, and rubber composition Active JP5013516B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007175724A JP5013516B2 (en) 2007-07-04 2007-07-04 Medical rubber member, sterilized medical rubber member, and rubber composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007175724A JP5013516B2 (en) 2007-07-04 2007-07-04 Medical rubber member, sterilized medical rubber member, and rubber composition

Publications (2)

Publication Number Publication Date
JP2009011518A JP2009011518A (en) 2009-01-22
JP5013516B2 true JP5013516B2 (en) 2012-08-29

Family

ID=40353160

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007175724A Active JP5013516B2 (en) 2007-07-04 2007-07-04 Medical rubber member, sterilized medical rubber member, and rubber composition

Country Status (1)

Country Link
JP (1) JP5013516B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6537748B2 (en) 2016-12-28 2019-07-03 三菱電機株式会社 Power supply
US11772829B2 (en) 2018-06-27 2023-10-03 Mitsubishi Electric Corporation Power supply device
WO2023157953A1 (en) * 2022-02-18 2023-08-24 国立研究開発法人国立国際医療研究センター Surgical ink, production method for said ink, and surgical pen using said ink

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6351866A (en) * 1986-08-22 1988-03-04 株式会社 ニツシヨ− Rubber button
JP2002038011A (en) * 2000-07-24 2002-02-06 Shin Etsu Chem Co Ltd Antifungal silicone rubber composition

Also Published As

Publication number Publication date
JP2009011518A (en) 2009-01-22

Similar Documents

Publication Publication Date Title
JP5261175B2 (en) Radiation resistant silicone formulation and medical device produced thereby
JP5022368B2 (en) Method for sterilizing elastomeric sealing articles
ES2373585T3 (en) SEALING MEMBERS, ITEMS USING THE SAME AND PROCEDURES TO REDUCE STATIC FRICTION.
EP1675632B1 (en) Low extractable, thermoplastic syringe and tip cap
US8742032B2 (en) Medical appliance having a slidable coating layer and syringe
JPH0812816A (en) Internally lubricated elastomer suitable for biomedical application
JP2004532060A (en) Syringe and needle shield assembly and method for sterilizing the assembly
JP5013516B2 (en) Medical rubber member, sterilized medical rubber member, and rubber composition
JP2013189551A (en) Silicone elastomer composition, elastic member for medical appliance, and tube for medical use
JP2019519298A (en) Method for producing pre-filled non-glass containers
US5788977A (en) Method of making controlled release devices
JP2007244606A (en) Syringe, and method for manufacturing the same
US20020139088A1 (en) Polymeric syringe body and stopper
JP5770736B2 (en) Silicone rubber composition
US20230358326A1 (en) Non-return valve, drip chamber, port for needle-free metering of a liquid, back-flow barrier, infusion or transfusion system and method for producing a non-return valve
JPH08150216A (en) Tube connector
Grigoryan et al. Polymer materials of medical purpose and materials for dentistry
Ledig Silicone rubbers in medical applications–friction reduction with LSR Top Coat
JPH04135746A (en) Therapeutic rubber tube
AU2002254137A1 (en) Polymeric syringe body and stopper
JPS6083667A (en) Medical elastic sealer and medical drip set

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100208

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20111117

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111118

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20120111

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120111

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120601

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120601

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150615

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 5013516

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250